AG Health

Avant-Garde Holdings Americas (AGH), was established to create a portfolio of brands that will transform the global cannabis economy and ecosystem. The team is comprised of world-class scientists and business leaders in healthcare, agriculture, finance, sports, and hospitality. We have entered the market through the manufacture and production of natural products derived from industrial hemp extractions, with an emphasis on stimulating the receptors in the human body’s endocannabinoid system (ECS) with its proprietary formulations in addition to presenting and executing meaningful solutions to companies in the U.S., Canada, Latin America and Europe.